Home ›
Trademark Categories ›
Pharmaceuticals ›
2005 ›
LE ›
LEU-KIC
Trademark search for:
LEU-KIC
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2005-09-23 — Application filed
2005-09-30 — Application filed
2006-03-29 — Approved for pub - principal register
2006-03-29 — Assigned to examiner
2006-04-14 — Assigned to lie
2006-04-14 — Law office publication review completed
2006-05-17 — Notice of publication
2006-06-06 — Published for opposition
2006-06-06 — Opposition papers received at ttab
2006-06-07 — Opposition instituted no. 999999
2006-10-04 — Opposition dismissed no. 999999
2006-10-04 — Opposition terminated no. 999999
2006-11-21 — Noa mailed - sou required from applicant
2007-01-16 — Notice of allowance cancelled
2007-01-16 — Case assigned to ttab
2007-01-19 — Opposition instituted no. 999999
2007-07-05 — Opposition dismissed no. 999999
2007-07-05 — Opposition terminated no. 999999
2007-08-28 — Noa mailed - sou required from applicant
2008-01-11 — Assigned to examiner
2008-02-25 — Sou teas extension received
2008-02-25 — Sou extension 1 filed
2008-03-12 — Sou extension 1 granted
2008-10-27 — Application abandoned
2008-10-27 — Application abandoned
2008-10-27 — Final status recorded
Owner Information
Leukic US Trademark Ltd.
Mississauga, Ontario CA
Leukic US Trademark Ltd.
Mississauga, Ontario CA
Correspondent
Howard J. Shire, Esq. Kenyon & Kenyon LLP One Broadway New York, NY 10004-1050 UNITED STATES
Filing Details
Filing Date:
2005-09-23
Status Date:
2008-10-27
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.